Cargando…

Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer

Mostrar otras versiones (1)

The 21-gene recurrence score (RS) predicts the prognosis of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage breast cancer and the effectiveness of adding adjuvant chemotherapy on the basis of endocrine therapy to avoid excessive che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lizhe, Ma, Nan, Wang, Bin, Zhou, Can, Yan, Yu, Wang, Ke, He, Jianjun, Ren, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507352/ https://www.ncbi.nlm.nih.gov/pubmed/31186766 http://dx.doi.org/10.3892/ol.2019.10277

Ejemplares similares

Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2021)

Significant prognostic values of aquaporin mRNA expression in breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2019)

Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2020)

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer
por: Thaker, Nikhil G, et al.
Publicado: (2015)

Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
por: Liu, Jiaxiang, et al.
Publicado: (2023)

Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
por: Wu, San-Gang, et al.
Publicado: (2019)

Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer
por: Yang, David D., et al.
Publicado: (2020)

The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
por: Lee, Moo Hyun, et al.
Publicado: (2015)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer
por: Brufsky, Adam M.
Publicado: (2014)

Green tea consumption and risk of breast cancer: A systematic review and updated meta-analysis of case-control studies
por: Yu, Shibo, et al.
Publicado: (2019)

The Role of the 21-Gene Recurrence Score(®) Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
por: Yordanova, Mariya, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role
por: Zhu, Lizhe, et al.
Publicado: (2020)

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer
por: Layman, Rachel M., et al.
Publicado: (2022)

Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy
por: Ren, Kang, et al.
Publicado: (2022)

PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK
por: Zhu, Lizhe, et al.
Publicado: (2022)

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients
por: Ligorio, Francesca, et al.
Publicado: (2021)

A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
por: Alvarado, Michael D., et al.
Publicado: (2015)

Growth pattern can be used as a new characteristic to predict malignancy in breast cancer
por: Wang, Bin, et al.
Publicado: (2020)

Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis
por: Yu, Shibo, et al.
Publicado: (2020)

Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis
por: Kim, Yi-Jun, et al.
Publicado: (2019)

21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
por: Wu, San-Gang, et al.
Publicado: (2019)

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
por: Chen, Jonathan, et al.
Publicado: (2018)

Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
por: Taylor, Caitlin, et al.
Publicado: (2023)

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
por: Makower, Della, et al.
Publicado: (2021)

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
por: Hannouf, Malek B, et al.
Publicado: (2012)

Early Stages of the Natriuretic Hormone Story
por: Lichardus, Branislav
Publicado: (2014)

Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer
por: Huang, Lei, et al.
Publicado: (2023)

A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
por: Sparano, Joseph A., et al.
Publicado: (2017)

Gene Expression Assays for Early-Stage Hormone Receptor–Positive Breast Cancer: Understanding the Differences
por: Nunes, Ana Tablante, et al.
Publicado: (2017)

The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer
por: Ozveren, Ahmet, et al.
Publicado: (2023)

Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis
por: de Medeiros Rimkus, Carolina, et al.
Publicado: (2013)

Early Stage Relapsing Polychondritis Diagnosed by Nasal Septum Biopsy
por: Kobayashi, Takaaki, et al.
Publicado: (2015)

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer
por: Alshamsan, Bader, et al.
Publicado: (2021)

Significance of Oncotype DX 21-Gene Test and Expression of Long Non-Coding RNA MALAT1 in Early and Estrogen Receptor-Positive Breast Cancer Patients
por: Huang, Zhen, et al.
Publicado: (2021)

Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer
por: Minami, Christina A., et al.
Publicado: (2020)

A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer
por: Zhu, Lizhe, et al.
Publicado: (2021)

Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients
por: Wu, Jiayi, et al.
Publicado: (2017)

Male Hormones for the Prevention of Relapses in Malaria
por: Gross, S. J.
Publicado: (1947)

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
por: Parsons, Benjamin M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hejhmea4u2rc1pidh2gdp3o34m